Advisor Group Holdings, Inc. Biovie Inc. Transaction History

Advisor Group Holdings, Inc.

$40.6 Billion
Q2 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Biovie Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,963 shares of BIVI stock, worth $10,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,963

Previous 5,763 31.23%

Holding current value

$10,977

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.4 - $0.56 $720 - $1,008	-1,800 Reduced 31.23%	3,963 $1,000
Q1 2024 May 10, 2024	SELL	$0.53 - $1.89 $702 - $2,504	-1,325 Reduced 18.69%	5,763 $3,000
Q4 2023 Feb 12, 2024	SELL	$1.22 - $5.24 $2,116 - $9,091	-1,735 Reduced 19.66%	7,088 $8,000
Q3 2023 Nov 13, 2023	SELL	$2.75 - $5.17 $566 - $1,065	-206 Reduced 2.28%	8,823 $30,000
Q2 2023 Aug 10, 2023	BUY	$4.09 - $8.29 $4,355 - $8,828	1,065 Added 13.37%	9,029 $38,000
Q1 2023 May 12, 2023	SELL	$4.89 - $10.53 $8,503 - $18,311	-1,739 Reduced 17.92%	7,964 $64,000
Q4 2022 Feb 10, 2023	BUY	$3.86 - $42.0 $25,726 - $279,930	6,665 Added 219.39%	9,703 $75,000
Q3 2022 Nov 14, 2022	BUY	$1.38 - $25.6 $3,725 - $69,120	2,700 Added 798.82%	3,038 $8,000
Q2 2022 Aug 10, 2022	SELL	$1.44 - $5.04 $953 - $3,336	-662 Reduced 66.2%	338 $0
Q1 2022 May 04, 2022	BUY	$2.74 - $5.65 $822 - $1,695	300 Added 42.86%	1,000 $5,000
Q2 2021 Aug 02, 2021	BUY	$10.57 - $21.61 $5,285 - $10,805	500 Added 250.0%	700 $11,000
Q1 2021 May 13, 2021	SELL	$14.35 - $44.81 $11,480 - $35,848	-800 Reduced 80.0%	200 $4,000
Q4 2020 Feb 10, 2021	SELL	$7.85 - $17.32 $39,250 - $86,600	-5,000 Reduced 83.33%	1,000 $17,000
Q3 2020 Nov 12, 2020	BUY	$9.0 - $265.0 $54,000 - $1.59 Million	6,000 New	6,000 $58,000

Others Institutions Holding BIVI

# of Institutions

Shares Held

4.73M

Call Options Held

17.2K

Put Options Held

27K

View Full List

About BIOVIE INC.

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

More about BIVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Biovie Inc. Transaction History